J Korean Ophthalmol Soc.  2001 Apr;42(4):638-646.

The Neuroprotective Effect of Intravitreal Melatonin Injection in Pressure-induced Retinal Ischemia

Affiliations
  • 1Department of Ophthalmology, Kyung Hee University Hospital.

Abstract

PURPOSE: The authors sought to determine the neuroprotective effect of melatonin in a model of ischemic injury in rabbit retina.
METHODS
Ischemia was induced by high intraocualr pressure. A dose of 100 microgram of melatonin or dimethyl sulfoxide(DMSO) alone was injected intravitreally just after the induction of ischemia. After 7 and 14 days, the neuroprotective effect of melatonin on ischemic retina was examined with light microscope and transmission electron microscope.
RESULTS
The authors found reduction of cytoplasm of retinal ganglion cell(RGC), vacuole formation, chromatin condensation and rupture of nuclear membrane in ischemia-injured eyes treated with DMSO alone. But in melatonin treated eyes, we found that RGC layer's thickness and number of RGC reduced and destruction of cytoplasmic organells and nuclear damage were minimal. The partial recovery of wave is noted in melatonin-treated eyes after ischemia induction.
CONCLUSIONS
The melatonin(100 microgram) protected the rabbit retina from high intraocular pressure-induced ischemic injury when administered intravitreally. Melatonin may be useful to decrease neuronal damage in the retina as a result of ischemic injury. But further investigations are neccesary to decide effective concentration, route and time of administration.

Keyword

Ganglion cell; Melatonin; Retinal ischemia

MeSH Terms

Chromatin
Cytoplasm
Dimethyl Sulfoxide
Ganglion Cysts
Ischemia*
Melatonin*
Neurons
Neuroprotective Agents*
Nuclear Envelope
Retina
Retinaldehyde*
Rupture
Vacuoles
Chromatin
Dimethyl Sulfoxide
Melatonin
Neuroprotective Agents
Retinaldehyde
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr